News Novartis invests $100m in new malaria drugs Concerns are mounting over resistance to artemisinin
News Trump’s trade war with China could drive up US pharma costs New tariffs on goods coming from China could hit the US pharmaceutical industry, according to a new analysis – and even undermine President Trump’s pledge to drive down the price of medicin
Market Access Verona to take COPD hopeful into phase 3 Verona Pharma is to take lung drug RPL554 into late clinical development after a successful phase 2b trial.
Market Access Row over CF drug funding as NHS rejects Vertex offer Vertex 'astonished and dismayed' by NHS rejection
News Tenax trounced by phase 3 heart failure readout Shares in Tenax 85% of their value after its drug for patients with pulmonary hypertension caused by a form of heart failure flunked a phase 3 trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
